Annual SGA
$18.14 M
+$1.00 M+5.85%
December 31, 2023
Summary
- As of February 7, 2025, ALT annual SGA is $18.14 million, with the most recent change of +$1.00 million (+5.85%) on December 31, 2023.
- During the last 3 years, ALT annual SGA has risen by +$4.93 million (+37.30%).
- ALT annual SGA is now -19.15% below its all-time high of $22.43 million, reached on December 31, 2009.
Performance
ALT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$4.97 M
-$626.00 K-11.19%
September 30, 2024
Summary
- As of February 7, 2025, ALT quarterly SGA is $4.97 million, with the most recent change of -$626.00 thousand (-11.19%) on September 30, 2024.
- Over the past year, ALT quarterly SGA has increased by +$637.00 thousand (+14.70%).
- ALT quarterly SGA is now -25.23% below its all-time high of $6.65 million, reached on December 31, 2009.
Performance
ALT Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.01 B
-$103.52 M-5.43%
September 30, 2024
Summary
- As of February 7, 2025, ALT TTM SGA is -$2.01 billion, with the most recent change of -$103.52 million (-5.43%) on September 30, 2024.
- Over the past year, ALT TTM SGA has dropped by -$2.03 billion (-11185.80%).
- ALT TTM SGA is now -77688.60% below its all-time high of $2.59 million.
Performance
ALT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ALT Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.8% | +14.7% | -10000.0% |
3 y3 years | +37.3% | +19.6% | -10000.0% |
5 y5 years | +85.7% | +127.1% | -10000.0% |
ALT Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +17.7% | -11.2% | +31.6% | -99.2% | at low |
5 y | 5-year | at high | +113.4% | -11.2% | +146.6% | -292.7% | at low |
alltime | all time | -19.1% | >+9999.0% | -25.2% | +9877.9% | <-9999.0% | at low |
Altimmune Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $4.97 M(-11.2%) | $20.21 M(+2.3%) |
Jun 2024 | - | $5.59 M(+5.3%) | $19.75 M(+4.4%) |
Mar 2024 | - | $5.31 M(+22.6%) | $18.92 M(+4.3%) |
Dec 2023 | $18.14 M(+5.9%) | $4.33 M(-4.0%) | $18.14 M(+3.0%) |
Sep 2023 | - | $4.51 M(-5.2%) | $17.61 M(+0.1%) |
Jun 2023 | - | $4.76 M(+5.1%) | $17.59 M(+2.0%) |
Mar 2023 | - | $4.53 M(+19.1%) | $17.24 M(+0.6%) |
Dec 2022 | $17.13 M(+11.2%) | $3.81 M(-15.3%) | $17.13 M(+0.2%) |
Sep 2022 | - | $4.49 M(+1.9%) | $17.11 M(+2.0%) |
Jun 2022 | - | $4.41 M(-0.4%) | $16.77 M(+4.7%) |
Mar 2022 | - | $4.43 M(+17.2%) | $16.02 M(+3.9%) |
Dec 2021 | $15.41 M(+16.7%) | $3.78 M(-9.1%) | $15.41 M(-2.1%) |
Sep 2021 | - | $4.16 M(+13.6%) | $15.75 M(-0.4%) |
Jun 2021 | - | $3.66 M(-4.2%) | $15.81 M(+7.6%) |
Mar 2021 | - | $3.82 M(-7.1%) | $14.70 M(+11.3%) |
Dec 2020 | $13.21 M(+55.4%) | $4.11 M(-2.6%) | $13.21 M(+18.9%) |
Sep 2020 | - | $4.22 M(+65.8%) | $11.11 M(+22.4%) |
Jun 2020 | - | $2.55 M(+9.2%) | $9.08 M(+3.6%) |
Mar 2020 | - | $2.33 M(+15.7%) | $8.77 M(+3.1%) |
Dec 2019 | $8.50 M(-13.0%) | $2.01 M(-7.9%) | $8.50 M(-4.5%) |
Sep 2019 | - | $2.19 M(-2.0%) | $8.91 M(+2.6%) |
Jun 2019 | - | $2.23 M(+8.0%) | $8.68 M(-7.5%) |
Mar 2019 | - | $2.07 M(-14.6%) | $9.38 M(-3.9%) |
Dec 2018 | $9.77 M(+15.5%) | $2.42 M(+23.2%) | $9.77 M(+9.2%) |
Sep 2018 | - | $1.96 M(-33.1%) | $8.94 M(-10.7%) |
Jun 2018 | - | $2.93 M(+19.9%) | $10.01 M(+12.8%) |
Mar 2018 | - | $2.45 M(+53.6%) | $8.88 M(+4.9%) |
Dec 2017 | $8.46 M(+19.0%) | $1.59 M(-47.6%) | $8.46 M(-2.4%) |
Sep 2017 | - | $3.04 M(+69.3%) | $8.67 M(-2.8%) |
Jun 2017 | - | $1.79 M(-11.6%) | $8.92 M(+10.2%) |
Mar 2017 | - | $2.03 M(+12.5%) | $8.09 M(+11.5%) |
Dec 2016 | $7.11 M(+14.2%) | $1.80 M(-45.1%) | $7.25 M(+12.9%) |
Sep 2016 | - | $3.29 M(+240.3%) | $6.43 M(+47.1%) |
Jun 2016 | - | $966.60 K(-19.0%) | $4.37 M(-16.3%) |
Mar 2016 | - | $1.19 M(+22.3%) | $5.22 M(-16.1%) |
Dec 2015 | $6.22 M | $975.80 K(-20.7%) | $6.22 M(-20.9%) |
Sep 2015 | - | $1.23 M(-32.3%) | $7.87 M(-20.0%) |
Jun 2015 | - | $1.82 M(-17.2%) | $9.83 M(-5.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2015 | - | $2.20 M(-16.2%) | $10.43 M(-4.4%) |
Dec 2014 | $10.91 M(-17.8%) | $2.62 M(-17.9%) | $10.91 M(-15.2%) |
Sep 2014 | - | $3.19 M(+31.9%) | $12.87 M(-6.5%) |
Jun 2014 | - | $2.42 M(-9.6%) | $13.76 M(+0.6%) |
Mar 2014 | - | $2.68 M(-41.5%) | $13.68 M(+3.0%) |
Dec 2013 | $13.28 M(+14.2%) | $4.58 M(+12.1%) | $13.28 M(+17.3%) |
Sep 2013 | - | $4.09 M(+75.2%) | $11.32 M(+7.7%) |
Jun 2013 | - | $2.33 M(+2.3%) | $10.51 M(-4.1%) |
Mar 2013 | - | $2.28 M(-13.1%) | $10.96 M(-5.8%) |
Dec 2012 | $11.63 M(-18.7%) | $2.62 M(-19.9%) | $11.63 M(-0.5%) |
Sep 2012 | - | $3.28 M(+17.8%) | $11.68 M(-0.1%) |
Jun 2012 | - | $2.78 M(-5.7%) | $11.69 M(-5.1%) |
Mar 2012 | - | $2.95 M(+10.1%) | $12.32 M(-13.9%) |
Dec 2011 | $14.31 M(-20.6%) | $2.68 M(-18.4%) | $14.31 M(-15.9%) |
Sep 2011 | - | $3.28 M(-3.7%) | $17.02 M(+0.6%) |
Jun 2011 | - | $3.41 M(-31.0%) | $16.92 M(-4.0%) |
Mar 2011 | - | $4.94 M(-8.4%) | $17.63 M(-2.1%) |
Dec 2010 | $18.02 M(-19.7%) | $5.39 M(+69.6%) | $18.02 M(-6.5%) |
Sep 2010 | - | $3.18 M(-22.9%) | $19.27 M(-13.7%) |
Jun 2010 | - | $4.12 M(-22.6%) | $22.32 M(-1.3%) |
Mar 2010 | - | $5.33 M(-19.9%) | $22.61 M(+0.8%) |
Dec 2009 | $22.43 M(+15.6%) | $6.65 M(+6.8%) | $22.43 M(+9.3%) |
Sep 2009 | - | $6.22 M(+41.0%) | $20.53 M(+7.4%) |
Jun 2009 | - | $4.42 M(-14.2%) | $19.11 M(-3.8%) |
Mar 2009 | - | $5.15 M(+8.5%) | $19.86 M(+2.4%) |
Dec 2008 | $19.40 M(+39.7%) | $4.74 M(-1.3%) | $19.40 M(-2.7%) |
Sep 2008 | - | $4.80 M(-7.2%) | $19.93 M(+9.0%) |
Jun 2008 | - | $5.17 M(+10.6%) | $18.28 M(+39.5%) |
Mar 2008 | - | $4.68 M(-11.3%) | $13.11 M(+20.2%) |
Dec 2007 | $13.88 M(+64.2%) | $5.28 M(+67.5%) | $10.91 M(+14.5%) |
Sep 2007 | - | $3.15 M(+27.1%) | $9.53 M(+17.8%) |
Mar 2007 | - | $2.48 M(-36.4%) | $8.09 M(+41.0%) |
Dec 2006 | $8.45 M(+5698.3%) | $3.90 M(+142.6%) | $5.73 M(+197.4%) |
Sep 2006 | - | $1.61 M(+1489.6%) | $1.93 M(+420.0%) |
Jun 2006 | - | $101.10 K(-20.0%) | $370.80 K(+37.5%) |
Mar 2006 | - | $126.40 K(+35.2%) | $269.70 K(+88.2%) |
Dec 2005 | $145.80 K | $93.50 K(+87.8%) | $143.30 K(+187.8%) |
Sep 2005 | - | $49.80 K | $49.80 K |
FAQ
- What is Altimmune annual SGA?
- What is the all time high annual SGA for Altimmune?
- What is Altimmune annual SGA year-on-year change?
- What is Altimmune quarterly SGA?
- What is the all time high quarterly SGA for Altimmune?
- What is Altimmune quarterly SGA year-on-year change?
- What is Altimmune TTM SGA?
- What is the all time high TTM SGA for Altimmune?
- What is Altimmune TTM SGA year-on-year change?
What is Altimmune annual SGA?
The current annual SGA of ALT is $18.14 M
What is the all time high annual SGA for Altimmune?
Altimmune all-time high annual SGA is $22.43 M
What is Altimmune annual SGA year-on-year change?
Over the past year, ALT annual SGA has changed by +$1.00 M (+5.85%)
What is Altimmune quarterly SGA?
The current quarterly SGA of ALT is $4.97 M
What is the all time high quarterly SGA for Altimmune?
Altimmune all-time high quarterly SGA is $6.65 M
What is Altimmune quarterly SGA year-on-year change?
Over the past year, ALT quarterly SGA has changed by +$637.00 K (+14.70%)
What is Altimmune TTM SGA?
The current TTM SGA of ALT is -$2.01 B
What is the all time high TTM SGA for Altimmune?
Altimmune all-time high TTM SGA is $2.59 M
What is Altimmune TTM SGA year-on-year change?
Over the past year, ALT TTM SGA has changed by -$2.03 B (-11185.80%)